B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data-Reference-Cited by-同舟云学术

B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data

Published:2018-07-31 Issue:1 Volume:7 Page:
ISSN:2046-4053
Container-title:Systematic Reviews
language:en
Short-container-title:Syst Rev

Author:

Pufulete Maria^ORCID,Maishman Rachel,Dabner Lucy,Higgins Julian P. T.,Rogers Chris A.,Dayer Mark,MacLeod John,Purdy Sarah,Hollingworth William,Schou Morten,Anguita-Sanchez Manuel,Karlström Patric,Shochat Michael Kleiner,McDonagh Theresa,Nightingale Angus K.,Reeves Barnaby C.

Funder

Health Technology Assessment Programme

Publisher

Springer Science and Business Media LLC

Subject

Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13643-018-0776-8.pdf

Reference49 articles.

1. Hollingworth W, Biswas M, Maishman RL, Dayer MJ, McDonagh T, Purdy S, Reeves BC, Rogers CA, Williams R, Pufulete M. The healthcare costs of heart failure during the last five years of life: a retrospective cohort study. Int J Cardiol. 2016;224:132–8.

2. Sharma A, Ezekowitz JA. Similarities and differences in patient characteristics between heart failure registries versus clinical trials. Current heart failure reports. 2013;10(4):373–9.

3. Felker GM, Hasselblad V, Hernandez AF, O'Connor CM. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Am Heart J. 2009;158(3):422–30.